Equivalence Evaluations News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Equivalence Evaluations. Real-time updates on events, politics, business and more.

United States - Patent - FTC Challenges More Patent Listings In The FDA's Orange Book

May 17, 2024

The Federal Trade Commission (FTC) has been busy scrutinizing patent listings in the Food and Drug Administration's (FDA) publication of "Approved Drug Products with Therapeutic Equivalence Evaluations...

Drug Administration Key Takeaways Orange Book Federal Trade Commission Drug Products Equivalence Evaluations

Source: mondaq.com

Following Recent Policy Statement, FTC 'Disputes' 100+ Patent Listings In FDA Orange Book - Patent

November 24, 2023

The US Federal Trade Commission (FTC) sent letters on November 7, 2023, accusing 10 companies of improperly listing drug delivery device patents in the US Food and Drug Administration (FDA)...

United States Drug Administration Us Federal Trade Commission Us Court Trade Commission Orange Book

Source: mondaq.com

Status Of Reverse Payment Cases Against Pharmaceutical Companies - Patent

August 9, 2023

Reverse payment cases arise in the context of settlement agreements between brand-name pharmaceutical companies and generic drug manufacturers to resolve patent litigation under the Hatch-Waxman Act...

United States Christopherm Holman Lowenstein Sandler Phillip Areeda Jennifere Sturiale Jonathan Lewis

Source: mondaq.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Equivalence Evaluations News Today

United States - Patent - FTC Challenges More Patent Listings In The FDA's Orange Book

Following Recent Policy Statement, FTC 'Disputes' 100+ Patent Listings In FDA Orange Book - Patent

Status Of Reverse Payment Cases Against Pharmaceutical Companies - Patent

Explore More Categories